Verastem (VSTM) Non Operating Income (2019 - 2026)
Verastem (VSTM) recorded quarterly Non Operating Income of -$61000.0 in Q1 2026, down 258.82% quarter-over-quarter from -$17000.0 in Q4 2025, and down 52.5% on a YoY basis from -$128421.1 in Q1 2025.
Verastem (VSTM) Non Operating Income (2019 - 2026) Analysis & Trends
Verastem's Non Operating Income history runs 7 years deep, the most recent figure standing at -$61000.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 52.5% year-over-year to -$61000.0; the TTM figure through Mar 2026 stood at -$225000.0 (down 69.17% YoY), while the FY2025 annual figure was -$203000.0, down 65.04% from the prior year.
- Non Operating Income was -$61000.0 for Q1 2026 at Verastem, down from -$17000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $28000.0 in Q1 2022 to a low of -$110000.0 in Q2 2025.
- Historically, Non Operating Income has averaged -$26470.6 across 5 years, with a median of -$24000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income plunged 766.67% in 2023, then jumped 116.33% in 2024.
- A 5-year view of Non Operating Income shows it stood at -$7000.0 in 2022, then sank by 600.0% to -$49000.0 in 2023, then surged by 116.33% to $8000.0 in 2024, then tumbled by 312.5% to -$17000.0 in 2025, then plunged by 258.82% to -$61000.0 in 2026.
- The last three Non Operating Income figures came in at -$61000.0 (Q1 2026), -$17000.0 (Q4 2025), and -$37000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | -61,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -110,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | -77,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Mar 31, 2024 | -30,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -40,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Dec 31, 2022 | -7,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Mar 31, 2020 | 1.30 Mn |
| Dec 31, 2019 | 600,000.00 |